James B Wetmore

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. pmc Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs
    James B Wetmore
    Department of Medicine, Division of Nephrology, University of Kansas Medical Center, Kansas City, KS, USA
    Int J Nephrol Renovasc Dis 1:5-17. 2008
  2. pmc Atrial fibrillation and risk of stroke in dialysis patients
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension, University of Kansas School of Medicine, Kansas City, KS, USA
    Ann Epidemiol 23:112-8. 2013
  3. pmc Geographic variation in HMG-CoA reductase inhibitor use in dialysis patients
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension, University of Kansas School of Medicine, Mailstop 3002, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA
    J Gen Intern Med 27:1475-83. 2012
  4. pmc The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients
    James B Wetmore
    Division of Nephrology and Hypertension, Department of Medicine, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA
    Kidney Int 81:469-76. 2012
  5. pmc Association of 25-hydroxyvitamin D deficiency with NT-pro BNP levels in patients with acute myocardial infarction: a cross-sectional analysis
    James B Wetmore
    Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS, USA
    BMC Res Notes 4:542. 2011
  6. pmc Role of lean body mass in estimating glomerular filtration rate in Alzheimer disease
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension and The Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Nephrol Dial Transplant 26:2222-31. 2011
  7. pmc Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRD
    James B Wetmore
    Division of Nephrology and Hypertension, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA
    J Clin Endocrinol Metab 96:E57-64. 2011
  8. pmc Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension, University of Kansas School of Medicine, Kansas City, KS 66160, USA
    Am J Kidney Dis 58:73-83. 2011
  9. pmc Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD
    James B Wetmore
    University of Kansas Medical Center, MS 3002, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
    Clin J Am Soc Nephrol 5:110-6. 2010
  10. ncbi request reprint An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease
    James B Wetmore
    The Department of Medicine, San Francisco VAMC University of California, San Francisco, CA 94121, USA
    Hum Genet 120:201-10. 2006

Detail Information

Publications31

  1. pmc Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs
    James B Wetmore
    Department of Medicine, Division of Nephrology, University of Kansas Medical Center, Kansas City, KS, USA
    Int J Nephrol Renovasc Dis 1:5-17. 2008
    ....
  2. pmc Atrial fibrillation and risk of stroke in dialysis patients
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension, University of Kansas School of Medicine, Kansas City, KS, USA
    Ann Epidemiol 23:112-8. 2013
    ..Both stroke and chronic atrial fibrillation (AF) are common in dialysis patients, but uncertainty exists in the incidence of new strokes and the risk conferred by chronic AF...
  3. pmc Geographic variation in HMG-CoA reductase inhibitor use in dialysis patients
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension, University of Kansas School of Medicine, Mailstop 3002, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA
    J Gen Intern Med 27:1475-83. 2012
    ..Little is known about the demographic, clinical, and geographic factors associated with statin exposure in end-stage renal disease (ESRD) patients...
  4. pmc The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients
    James B Wetmore
    Division of Nephrology and Hypertension, Department of Medicine, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA
    Kidney Int 81:469-76. 2012
    ....
  5. pmc Association of 25-hydroxyvitamin D deficiency with NT-pro BNP levels in patients with acute myocardial infarction: a cross-sectional analysis
    James B Wetmore
    Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS, USA
    BMC Res Notes 4:542. 2011
    ..abstract:..
  6. pmc Role of lean body mass in estimating glomerular filtration rate in Alzheimer disease
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension and The Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Nephrol Dial Transplant 26:2222-31. 2011
    ..Since AD is characterized by sarcopenia and other changes in body composition, which are known to influence GFR, a determination of how lean mass (LM) affects estimation of GFR in AD patients is important...
  7. pmc Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRD
    James B Wetmore
    Division of Nephrology and Hypertension, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA
    J Clin Endocrinol Metab 96:E57-64. 2011
    ..The positive association of elevated fibroblast growth factor-23 (FGF23) with PTH levels in the setting of secondary hyperparathyroidism is paradoxical to the purported effects of FGF23 to suppress PTH secretion...
  8. pmc Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension, University of Kansas School of Medicine, Kansas City, KS 66160, USA
    Am J Kidney Dis 58:73-83. 2011
    ..We constructed a novel database that permits detailed exploration into the demographic, clinical, and geographic factors associated with the use of these agents in hypertensive long-term dialysis patients...
  9. pmc Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD
    James B Wetmore
    University of Kansas Medical Center, MS 3002, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
    Clin J Am Soc Nephrol 5:110-6. 2010
    ..The effects of various treatments for secondary hyperparathyroidism on FGF23 levels in ESRD have not been examined in a clinical trial...
  10. ncbi request reprint An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease
    James B Wetmore
    The Department of Medicine, San Francisco VAMC University of California, San Francisco, CA 94121, USA
    Hum Genet 120:201-10. 2006
    ..This "protective" haplotype may encompass loci with functional significance in the ACE gene...
  11. doi request reprint The ABCs of cardioprotection in dialysis patients: a systematic review
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension, University of Kansas School of Medicine, Kansas City, KS 66160, USA
    Am J Kidney Dis 53:457-66. 2009
    ....
  12. pmc Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients
    James B Wetmore
    Department of Medicine, San Francisco VAMC University of California, California, USA
    Nephrology (Carlton) 13:593-600. 2008
    ..We undertook a prospective study to determine whether these markers could predict mortality in ESRD...
  13. pmc Impact of race on cumulative exposure to antihypertensive medications in dialysis
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension, University of Kansas School of Medicine, Kansas City, KS, USA
    Am J Hypertens 26:234-42. 2013
    ..However, cumulative exposure has not been investigated in dialysis patients...
  14. pmc Stroke and the "stroke belt" in dialysis: contribution of patient characteristics to ischemic stroke rate and its geographic variation
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension
    J Am Soc Nephrol 24:2053-61. 2013
    ..Regional efforts to increase primary prevention in the "stroke belt" or to better educate dialysis patients on the signs of stroke so that they may promptly seek care may improve stroke care and outcomes in dialysis patients. ..
  15. pmc Impact of a modified data capture period on Liu comorbidity index scores in Medicare enrollees initiating chronic dialysis
    Sally K Rigler
    Department of General and Geriatric Medicine, University of Kansas School of Medicine, 3901 Rainbow Boulevard, MS 1037, Kansas City, KS 66160, USA
    BMC Nephrol 14:51. 2013
    ..The 270 day survival requirement results in sample size reductions and potential survivor bias. An earlier and shorter time-frame for data capture could be beneficial, if sufficiently similar comorbidity information could be ascertained...
  16. pmc Association of race with cumulative exposure to statins in dialysis
    James B Wetmore
    Division of Nephrology and Hypertension, Department of Medicine, University of Kansas School of Medicine, Kansas City, USA
    Am J Nephrol 36:90-6. 2012
    ....
  17. pmc Considering health insurance: how do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage?
    James B Wetmore
    Division of Nephrology and Hypertension, Department of Medicine, University of Kansas School of Medicine, KS, USA
    Nephrol Dial Transplant 25:198-205. 2010
    ..How these patients differ from non-Medicaid-enrolled incident dialysis patients and how these differences have changed over time have not been systematically examined...
  18. doi request reprint Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients
    Theresa I Shireman
    Department of Preventive Medicine and Public Health and the Landon Center on Aging, University of Kansas Medical Center, Kansas City, KS, USA
    Am J Kidney Dis 56:1108-16. 2010
    ..The economic implications of these treatment regimens have not been explored...
  19. doi request reprint Transient impact of automated glomerular filtration rate reporting on drug dosing for hospitalized older adults with concealed renal insufficiency
    Jessica L Kalender-Rich
    Division of General and Geriatric Medicine, Department of Internal Medicine, University of Kansas School of Medicine, Kansas City, Kansas, USA
    Am J Geriatr Pharmacother 9:320-7. 2011
    ..Older adults with concealed renal insufficiency are at risk of medication dosing errors. It is not known whether automated estimated glomerular filtration rate (eGFR) reporting is associated with reduced dosing errors in this population...
  20. doi request reprint Race, Ethnicity, and State-by-State Geographic Variation in Hemorrhagic Stroke in Dialysis Patients
    James B Wetmore
    Department of Medicine, Division of Nephrology and Hypertension, The Kidney Institute, Department of Biostatistics, Department of Preventive Medicine and Public Health, Department of Medicine, and, The Landon Center on Aging, University of Kansas School of Medicine, Kansas City, Kansas
    Clin J Am Soc Nephrol 9:756-63. 2014
    ..A similar pattern of geographic variation in ischemic strokes has also recently been reported in patients undergoing long-term dialysis, but whether this is also the case for hemorrhagic stroke is unknown...
  21. ncbi request reprint Interleukin-1 gene cluster polymorphisms predict risk of ESRD
    James B Wetmore
    Department of Medicine, San Francisco VAMC University of California, San Francisco, California 94121, USA
    Kidney Int 68:278-84. 2005
    ..Inflammation is regulated in part by genes of the interleukin-1 (IL-1) gene cluster. We hypothesized that polymorphisms in this gene cluster may be associated with risk of end-stage renal disease (ESRD)...
  22. doi request reprint A CD3+ count-based thymoglobulin induction regimen permits delayed introduction of calcineurin inhibitors in kidney transplantation
    Connie J Wang
    Division of Nephrology and Hypertension, Department of Pathology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Clin Transplant 26:900-9. 2012
    ..Here, we report our results of a novel CNI-sparing induction protocol, which utilizes a CD3+ cell count-based rATG treatment regimen when delayed graft function (DGF) develops in the immediate postoperative period...
  23. doi request reprint Discrepancies between creatinine- and cystatin C-based equations: implications for identification of chronic kidney disease in the general population
    James B Wetmore
    Division of Nephrology and Hypertension, Department of Medicine, University of Kansas School of Medicine, Kansas City, Kansas, USA
    Scand J Urol Nephrol 44:242-50. 2010
    ....
  24. doi request reprint Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?
    James B Wetmore
    Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Nat Clin Pract Nephrol 5:24-33. 2009
    ..Finally, we propose a novel treatment framework in which calcimimetics are the primary therapy for suppressing parathyroid hormone production in patients with end-stage renal disease...
  25. doi request reprint Does it matter how parathyroid hormone levels are suppressed in secondary hyperparathyroidism?
    Jason R Stubbs
    Division of Nephrology and Hypertension and The Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas, USA
    Semin Dial 24:298-306. 2011
    ..We also examine the potential nonclassical effects of these therapies on the renin-angiotensin-aldosterone system, proteinuria, vascular calcification, fibroblast growth factor-23, inflammation, and overall survival...
  26. pmc Association of decreased glomerular filtration rate with racial differences in survival after acute myocardial infarction
    James B Wetmore
    Division of Nephrology, Department of Medicine, University of Kansas School of Medicine, Kansas City, Kansas, USA
    Clin J Am Soc Nephrol 6:733-40. 2011
    ..However, whether there are racial differences in the prevalence or prognostic importance of renal insufficiency in AMI is unknown...
  27. doi request reprint The medicinal use of water in renal disease
    Connie J Wang
    Division of Nephrology and the Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Kidney Int 84:45-53. 2013
    ....
  28. doi request reprint Painless myocardial ischemia is associated with mortality in patients with chronic kidney disease
    James B Wetmore
    Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, Kans 66160, USA jwetmore kumc edu
    Nephron Clin Pract 122:9-16. 2012
    ..We hypothesized that the presence of PMI is inversely related to the level of kidney function and is associated with impaired survival in chronic kidney disease (CKD)...
  29. ncbi request reprint Effects of short-term alendronate on bone mineral density in haemodialysis patients
    James B Wetmore
    Department of Medicine, University of California, San Francisco, California 94143, USA
    Nephrology (Carlton) 10:393-9. 2005
    ..In this investigation, the effect of a short course of alendronate on BMD in haemodialysis (HD) patients is evaluated...
  30. doi request reprint Improvement of hemodialysis catheter function with tenecteplase: a phase III, open-label study: TROPICS 4
    Steven Fishbane
    Division of Nephrology, Winthrop University Hospital, 200 Old Country Rd, 135, Mineola, NY 11501, USA
    J Thromb Thrombolysis 31:99-106. 2011
    ..Tenecteplase administered as a 1 h or 1 h plus extended dwell was associated with improved HD catheter function in the TROPICS 4 trial...
  31. pmc Implications of donor disseminated intravascular coagulation on kidney allograft recipients
    Connie J Wang
    Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Clin J Am Soc Nephrol 6:1160-7. 2011
    ..The significance of donor DIC on recipient kidney function is poorly understood. Additionally, the significance of thrombocytopenia in recipients of kidneys from DIC-positive donors is understudied...